For use in calves 1-5 days of age, as a one-time immunotherapeutic treatment for reduction of mortality and clinical signs associated with calf scours caused by E. coli K99 diarrhea in neonatal calves.
Dosage: Aseptically administer 1 ml intravenously. 21 day slaughter withdrawal.
Early administration in the disease process stimulates non-antigen related defense mechanisms and enhances calf’s innate immune defense system to minimize and control damage caused by pathogenic E. coli.
Anaphylactoid reactions may occur. Antidote: Epinephrine.